Sofos Investments, Inc.
- SEC CIK
- 0001741736
- Latest filing
- May 8, 2026
ARWR holding history
Arrowhead Pharmaceuticals, Inc. in every 13F filed by Sofos Investments, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ARWR overviewAll 13F holders of ARWRFull Q1 2026 holdings
- Shares (Q2 2024)
- 0
- Sold out in Q2 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2024 | 0 | $0 | 0.0% | −13−100.0% | Sold out | Holders |
| Q1 2024 | 13 | $402 | <0.1% | +5+62.5% | Added | Holders |
| Q4 2023 | 8 | $244 | <0.1% | −1−11.1% | Reduced | Holders |
| Q3 2023 | 9 | $209 | <0.1% | −27−75.0% | Reduced | Holders |
| Q2 2023 | 36 | $171 | <0.1% | +11+44.0% | Added | Holders |
| Q1 2023 | 25 | $196 | <0.1% | −16−39.0% | Reduced | Holders |
| Q4 2022 | 41 | $182 | <0.1% | −256−86.2% | Reduced | Holders |
| Q3 2022 | 297 | – | – | −123−29.3% | Reduced | Holders |
| Q2 2022 | 420 | – | – | −132−23.9% | Reduced | Holders |
| Q1 2022 | 552 | – | – | −306−35.7% | Reduced | Holders |
| Q4 2021 | 858 | – | – | +850+10,625.0% | Added | Holders |
| Q3 2021 | 8 | – | – | 00.0% | Unchanged | Holders |
| Q2 2021 | 8 | $83.0K | <0.1% | +8 | New | Holders |